|
MMD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.211200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.958800E-01 |
| Normal-vs-Stage2 |
1.741610E-01 |
| Normal-vs-Stage3 |
2.121400E-01 |
| Normal-vs-Stage4 |
5.802300E-02 |
| Stage1-vs-Stage2 |
3.273800E-01 |
| Stage1-vs-Stage3 |
4.351600E-02 |
| Stage1-vs-Stage4 |
1.442210E-02 |
| Stage2-vs-Stage3 |
1.200440E-02 |
| Stage2-vs-Stage4 |
4.402700E-03 |
| Stage3-vs-Stage4 |
4.209400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.930600E-01 |
| Normal-vs-AfricanAmerican |
9.072000E-01 |
| Normal-vs-Asian |
1.854010E-02 |
| Caucasian-vs-AfricanAmerican |
9.083800E-01 |
| Caucasian-vs-Asian |
7.199400E-03 |
| AfricanAmerican-vs-Asian |
2.189200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.089200E-01 |
| Normal-vs-Female |
9.244200E-01 |
| Male-vs-Female |
4.990800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.882800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.390200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.685800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.148200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.171700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.210600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.350800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.039400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.592400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.349800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.779000E-03 |
| Classical-VS-Follicular |
4.00700000000587E-05 |
| Classical-VS-Other |
6.823400E-01 |
| Classical-VS-Normal |
4.206400E-01 |
| Tall-VS-Follicular |
1.01569999966244E-07 |
| Tall-VS-Other |
5.134000E-01 |
| Tall-VS-Normal |
5.421400E-03 |
| Follicular-VS-Other |
9.696400E-02 |
| Follicular-VS-Normal |
1.478830E-03 |
| Other-VS-Normal |
3.740800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.189800E-01 |
| Normal-vs-N1 |
2.627800E-02 |
| N0-vs-N1 |
1.195500E-03 |
|
|
